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Introduction
Androstenedione is produced in the adrenal gland 
and gonads, has a weak intrinsic androgenic activity 
(~ 20% of testosterone), and is a prohormone for 
androgens (testosterone) and estrogens.1 High levels 
of serum androstenedione may confer androgenic or 
estrogenic risk to women and men, respectively.2,3 
Children and adolescents are particularly vulnerable 
to the effects of androstenedione conversion to active 
sex steroids. The conversion of androstenedione to 
estrogens can cause feminisation of boys. In both boys 
and girls, the combined effects of excessive androgens 
and estrogens can induce premature puberty, and 
significantly compromise adult stature, by causing 
early closure of the growth plates of the long bones.2,3 
High-circulating androstenedione levels are indicated 
in virilising congenital adrenal hyperplasia, polycystic 
ovarian syndrome, and other causes of hirsutism in 
women. Specifically, high levels may cause disruption 
of normal sexual development, severe acne, excessive 
body hair, disruption of the menstrual cycle, and 
infertility in girls.2,3 Elevated androstenedione levels may 
occur as a result of adrenal or ovarian tumours.2,3
Increased androgen production, or a high androgenic 
activity, has also been shown to be associated 
with obesity or adiposity, metabolic disturbances, 
and development of metabolic syndrome in adult 
women.4,5 Specifically, obese women with increased 
androgens are more prone to metabolic disturbances, 
such as hyperinsulinaemia, type 2 diabetes mellitus, 
lipid abnormalities, and hypertension. Therefore, they 
may be at particular risk of developing atherosclerotic 
complications.6,7
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Abstract
Background: High androgenic activity in adolescent girls and adult women is associated with adiposity and 
metabolic disturbances. This study examined the relationship between salivary androstenedione levels, body 
composition, and physical activity levels in young girls. 
Method: Twenty-three girls (8.4 ± 0.9 years), nine of normal weight, and 14, overweight or obese, according 
to Centers for Disease Control and Prevention body mass index (BMI) percentile ranking, wore an ActiGraph® 
accelerometer for five days. Skin folds were measured for percentage body fat and fat-free mass calculation. 
Saliva samples were collected at home, three times in one day (upon waking, 30 minutes post-waking and in 
the evening). Previously published cut-points estimated the minutes of sedentary behaviour, light, moderate, 
moderate-to-vigorous, vigorous, and very vigorous physical activity. Meeting physical activity recommendations 
was defined as accumulating 60 minutes/day of moderate-to-vigorous physical activity. T-tests, correlation analysis, 
and analysis of variance, examined the relationships among the variables (alpha = p-value ≤ 0.05). 
Results: Thirty-five per cent of the girls met current physical activity recommendations. There were no differences 
between the normal weight and overweight or obese categories in terms of meeting physical activity 
recommendations, or salivary androstenedione levels. Evening salivary androstenedione levels were higher among 
girls who did not meet the physical activity recommendations (116.9 ± 15.3 pg/ml vs. 80.45 ± 8.5 pg/ml, p-value 
= 0.04). Salivary androstenedione levels at 30 minutes post-waking were positively correlated with BMI (r = 0.45, 
p-value = 0.03) and percentage body fat (r = 0.40, p-value = 0.05).
Conclusion: These research results were similar to those of circulating androgen research performed in adolescent 
girls and adult women, in that salivary androstenedione levels were positively correlated with BMI and percentage 
body fat in young girls. Meeting physical activity recommendations was associated with the maintenance of the 
normal diurnal rhythm of salivary androstenedione secretion.  
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In children and adolescents, high androgenic 
activity has been associated with polycystic ovarian 
syndrome, precocious puberty, and accelerated bone 
age, with relatively tall stature.8,9 All of these clinical 
features occur more frequently in obese children, than 
in children of normal weight.9,10 Furthermore, children 
with premature adrenarche may tend to obesity.11 
While an association between androgens, obesity, 
and metabolic syndrome, is well established in obese 
women, studies concerning this relationship are scarce 
in obese preadolescent and adolescent girls.12 In terms 
of a reduction in androgen levels, studies of obese 
women and obese adolescents, after menarche, have 
shown a normalisation of hyperandrogenaemia and 
metabolic disturbances after weight loss.13,14 Although 
these studies incorporated either moderate or vigorous 
physical activity as part of the weight loss intervention, 
the relationship between salivary androgen levels 
(specifically androstenedione), body composition and 
physical activity levels has yet to be determined.
The strong serum-saliva correlation for androstenedione 
(r = 0.77)15 suggests that serum androstenedione levels 
may be accurate ly estimated using saliva as a non-
invasive alternative specimen for examining androgenic 
risk.16,17 The aim of this study was to determine whether 
salivary androstenedione levels were associated with 
body composition indices in young girls. In addition, 
the relationship between physical levels and salivary 
androstenedione levels was determined.
Method
Participant selection
Participants were recruited via local after-school 
programmes, churches, junior and senior primary 
schools, and advertising in the newspaper. 
Inclusion in the study entailed the following. Girls had 
to be between the ages of seven and 10 years old, 
and both the parents and the child provided written 
consent and assent, respectively, in accordance with 
the University of KwaZulu-Natal’s institutional review 
board guidelines. Children could not participate if they 
had known cardiovascular disease, diabetes (type 1 or 
2), or any condition that limited their ability to perform 
physical activity. Participation was not restricted by 
physical activity levels, race or socio-economic status.
Study design
Twenty-five girls completed two study visits that were 
seven days apart. 
The first visit included the following procedures: 
• Informed consent and assent
• Resting blood pressure measurement
• Height and weight measurement
• Blood draw (this study formed part of a larger, 
more comprehensive work, examining the 
existence of metabolic syndrome in young girls 
using blood markers. These blood results are not 
presented here).
• Completion of questionnaires (demographics and 
physical activity
• Tanner staging (parent proxy) 
• Distribution and explanation of activity monitors, 
physical activity log books and saliva collection 
kits. 
The second visit occurred seven days later, and 
included the following procedures:
• Resting blood pressure measurement
• Return of activity monitors, physical activity log 
books and saliva collection kits
• Skin folds measurement. 
Upon completion of the study, participants and one 
parent each received a pedometer. For this study, only 
height, weight, skin fold, saliva, and physical activity 
(from activity monitors) data were used.
Sexual maturity 
Sexual maturity was determined by Tanner staging via 
parent proxy report, and the parents were also asked 
whether their daughters had started menarche. The 
parents of the participants viewed sketches of stages 
of sexual maturation, identified their children’s personal 
development, and then placed the sheets in an 
envelope, and sealed them before returning them to 
the investigator. For Tanner stages I and II, this method 
has been shown to be as valid as Tanner staging by a 
physician, without the increased burden placed on the 
child.18 
Anthropometric data
Height was measured to the nearest 0.1 cm, using a wall-
mounted stadiometer (Perspective Enterprises, Portage, 
Michigan, USA). Weight was measured to the nearest 
0.1 kg, using a portable electronic scale (Model number 
68987, Befour, Saukville, Wisconsin, USA). Both height 
and weight were measured in duplicate, with shoes off, 
but wearing lightweight clothing. Age- and gender-
adjusted body mass index (BMI) was calculated as kg/
m2 according to the Centers for Disease Control and 
Prevention guidelines.19 
articipants were grouped into one of the following 
three BMI categories: 
• Normal (< 85th percentile)
• Overweight (85th-94th percentile)
• Obese (≥ 95th percentile). 
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Given the low number of participants who were 
considered overweight (n = 4), the participants were 
placed into two BMI groups for the statistical analysis, 
namely normal weight (n = 8, 35%) and overweight or 
obese (n = 15, 65%).
Total percentage body fat was determined by skin 
fold measurements from the triceps and calf (CRE100 
Lange®, Beta Technology, Sana Cruz, California, USA). 
Trained personnel took the measurements in duplicate, 
using procedures outlined by the American College 
of Sports Medicine.20 Age- and gender-appropriate 
equations were used to calculate percentage body 
fat. Once body fat percentage was determined, the 
amount of fat and fat-free mass was then calculated.
Physical activity assessment 
Participants wore an ActiGraph® accelerometer (GT1M, 
ActiGraph LLC, Pensacola, Florida, USA) for five days, 
including two weekend days. The activity monitor was 
worn during waking hours around the waist. To increase 
compliance, participants called the laboratory each 
morning, and indicated that they were wearing the 
activity monitor. Study staff followed up with children 
who did not call the laboratory each day. Data from 
the ActiGraph® determined the amount of time spent 
on being sedentary, and on light, moderate, moderate-
to-vigorous,vigorous and very vigorous physical activity 
per day. 
Data reduction
Epoch length was set at one-minute intervals. Data were 
included if the ActiGraph® was worn for at least eight 
hours and four days. The amount of time spend being 
sedentary as well as on light, moderate and vigorous 
physical activity was determined using Freedson’s cut-
points.21 Light activity was classified a ≥ 1.5 METs and < 4 
METs. Moderate physical activity was classified as 4-6.9 
metabolic equivalent of tasks (METs), vigorous was 7-8.9 
METs and very vigorous ≥ 9 METs. Moderate-to-vigorous 
physical activity was defined as activities ≥ 4 METs. 
Participants were classified as meeting physical activity 
recommendations if they accumulated 60 minutes of 
moderate-to-vigorous physical activity per day.22 
Saliva collection
The children, together with a parent or guardian, 
were trained in the saliva collection procedure. They 
were requested to adhere as closely as possible to the 
following precautions. 
The children had to: 
• Avoid eating a major meal within 60 minutes of 
sample collection.
• Avoid consuming dairy products for 20 minutes 
before sample collection.
• Avoid eating foods with high sugar, acidity, or 
caffeine content, immediately before sample 
collection (since these might compromise the 
assay by lowering saliva pH, and increasing 
bacterial growth).
• Rinse the mouth with water to remove food residue 
before sample collection, and swallow to increase 
hydration.
• Wait at least 10 minutes after rinsing before 
collecting saliva, to avoid sample dilution.
Saliva samples were collected at home, three times 
in one day [upon waking, 30 minutes post-waking, 
and in the evening (~8 pm)]. Saliva samples were 
collected via unstimulated, passive drool, over a time 
period of three minutes. The children were asked to 
lean slightly forward while seated, and tilt their heads 
down and accumulate saliva in the floor of the mouth 
for a minute. At the end of that time, the saliva was 
swallowed, and they then had to accumulate saliva 
for a further three minutes. During those three minutes, 
they could dribble the saliva through a 5 cm plastic 
straw, into a pre-weighed polypropylene cryovial 
(2 ml capacity) at any time. Care was taken to allow the 
saliva to dribble into the collecting tubes, with minimal 
orofacial movement. Samples were refrigerated 
immediately after collection in home freezers (-20 oC), 
and kept frozen until reaching the laboratory, after 
which they were stored at -70oC until analysis.
Salivary androstenedione 
Salivary androstenedione was measured using an 
enzyme immunoassay (Salimetrics®, State College, 
Pensylvannia, USA). All samples were analysed in 
duplicate, with the inter- and intra-assay coefficients of 
variation averaging 4.8% and 5.5%, respectively. 
Statistical analysis
Of the 25 girls who participated in the study, 23 
provided complete data that were used in the 
analysis. Descriptive statistics were calculated for 
the total sample. Data were presented as mean 
± standard deviation (SD). Student’s t-tests were 
run to examine differences in the demographic 
characteristics of the two groups. Chi-square analysis 
determined differences in meeting physical activity 
recommendations by BMI category. Linear regression 
was performed controlling for Tanner stage. Tanner 
stage was shown not to have an impact on the salivary 
androstenedione, body composition, or physical 
activity measurements (results not presented). Pearson 
correlations examined the relationship between 
salivary androstenedione variables, physical activity 
(moderate, vigorous, very vigorous and moderate-to-
vigorous), fat-free mass, body fat percentage, and 
BMI. A 3 x 2 repeated measures analysis of variance 
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(ANOVA) was used to examine differences in salivary 
androstenedione levels (upon waking, 30 minutes 
post-waking and in the evening), and BMI group, 
and salivary androstenedione levels (upon waking, 30 
minutes post-waking and in the evening), and meeting 
physical activity recommendations. A 3 x 2 repeated 
measures ANOVA was used to examine differences in 
salivary androstenedione levels (waking, 30 minutes 
post waking and evening) and BMI group. Tukey’s 
post-hoc analysis was completed when appropriate. 
All statistical analyses were conducted using SAS® 
(version 9.2, Research Triangle, North Carolina, USA) 
and statistical significance was set at p-value < 0.05.
Results
With regard to the sexual maturity of the girls, the 
number in each of the Tanner stages was as follows:
• Breast stage development: 11 in Tanner stage I, 
and 12 in Tanner stage II
• Pubic hair development: 18 in Tanner stage I, and 
5 in Tanner stage II. 
In addition, none of the girls indicated that they 
had started menarche. The descriptive physical, 
anthropometric, physical activity, and daily salivary 
androstenedione data (morning, 30 minutes post-
waking, and in the evening) for the girls (n = 23) are 
presented in Table I. In general, the girls of normal 
weight were younger and lighter, and had less body 
fat, fat-free mass, and fat mass. The amount of time 
spent on different physical activity intensities, and 
salivary androstenedione levels, were similar between 
the two groups. 
The chi-square analysis revealed no difference in 
meeting physical activity recommendations by BMI 
category (two levels, normal vs. overweight or obese). 
In the normal-weight group, 50% of the girls met the 
physical activity recommendations, while 50% did not. 
In the overweight or obese group, 33% met the physical 
activity recommendations, while 66% did not.
Table II provides the results for the correlations between 
time spent on sedentary behaviour, or different levels 
of physical activity and fat-free mass, percentage 
body fat, and BMI. There were significant negative 
correlations between time spent on vigorous physical 
activity and body fat percentage (r = -0.50, p-value 
= 0.02) and BMI (r = -0.43, p-value = 0.04), and time 
spent on very vigorous physical activity and body 
fat percentage (r = -0.46, p-value = 0.03) and BMI 
(r = -0.43, p-value = 0.04).
Table III provides the results for the correlations 
between body composition indices (fat-free mass, 
percentage body fat, and BMI) and the salivary 
androstenedione values upon waking, at 30 minutes 
post-waking, and in the evening. There were 
significant positive correlations between salivary 
androstenedione at 30 minutes post-waking and body 
fat percentage (r = 0.40, p-value = 0.05), as well as BMI 
(r = 0.45, p-value = 0.03). 
Table I: Descriptive data of young girls, including group anthropometry, 










Age (years) 7.88 ± 0.83a 8.73 ± 0.96 8.43 ± 0.99
Height (cm) 135.01 ± 6.15 140.82 ± 8.93 138.80 ± 8.42
Weight (kg) 28.98 ± 2.77a 47.05 ± 13.01 40.76 ± 13.70
Body fat (%) 19.72 ± 4.18a 34.01 ± 9.86 29.04 ± 10.76
Fat mass (kg) 5.74 ± 1.37a 17.03 ± 10.02 13.10 ± 9.73
Fat-free mass (kg) 23.24 ± 2.27a 30.02 ± 4.18 27.66 ± 4.87
Physical activity (minutes/day) 
Sedentary 865.20 ± 241.84 928.43 ± 60.82 908.31 ± 142.01
Light 338.65 ± 62.72 363.14 ± 51.97 355.35 ± 55.33
Moderate 53.99 ± 23.59 51.37 ± 14.20 52.20 ± 17.17
Moderate to 
vigorous
64.87 ± 31.55 54.66 ± 14.44 57.91 ± 21.15
Vigorous 10.88 ± 11.17 3.29 ± 2.43 5.70 ± 7.26
Very vigorous 1.03 ± 1.56 0.06 ± 0.17 0.46±  1.09
Salivary androstendione (pg/ml) 
Upon waking 80.93 ± 38.90 85.02 ± 56.52 83.60 ± 50.18
30 minutes 
post-waking
79.17 ± 39.94 105 ± 73.61 96.57 ± 64.22
In the evening 97.70 ± 52.31 105.30 ± 50.55 102.66 ± 50.11
a = significance p-value < 0.05
Table II: Correlations between sedentary behaviour or physical 
activity, and body composition indices
Physical activity 
level




Sedentary 0.10 0.13 0.13
Light 0.20 0.11 0.12




Vigorous -0.15 -0.50a -0.43a
Very vigorous -0.27 -0.46a -0.43a
a = significance p-value ≤ 0.05
Table III: Correlations between body composition indices and daily 
salivary androstenedione values








Body mass index 0.02 0.45a -0.00
a = significance p-value ≤ 0.05
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Figure 1 and Table IV provide the results for the ANOVA 
that was used to examine differences in salivary 
androstenedione levels, and meeting physical activity 
recommendations, as well as salivary androstenedione 
levels and BMI category (normal, or overweight or 
obese). The mean ± SD and 95% CI are provided for 
salivary androstenedione for the BMI classification. 
There were no interaction, group or time effects for 
salivary androstenedione levels between the normal 
and overweight or obese categories (see Table IV). 
However, there was a significant interaction effect 
(p-value = 0.04) for salivary androstenedione levels in 
the evening for the physical activity recommendations 
analysis. Specifically, post hoc testing demonstrated 
that the evening salivary androstenedione levels 
were significantly higher (+ 45%) for those girls who did 
not meet daily physical activity recommendations, 
compared to girls who did (see Figure 1). Interestingly, 
the girls meeting physical activity recommendations 
demonstrated the expected diurnal rhythm for 
androstenedione (higher in the morning, than in the 
evening), with the evening value being 23% lower 
than that of the waking value (see Figure 1). Also, the 
girls who did meet physical activity recommendations 
demonstrated a higher evening, compared to waking, 
level (+ 67%)
Discussion
This is the first study comparing salivary androstenedione 
concentrations between normal-weight and 
overweight or obese young girls. Importantly, it also 
analyses the association between their salivary 
androstenedione and physical activity levels.
Figure 2 displays a cross-section of expected 
salivary androstenedione levels for healthy women, 
from prepuberty to adulthood, as well as for 
prepubescent adrenal hyperplasia with significant 
hyperandrogenism.15,23 Specifically, for healthy six-to 
eight-year-old girls (n = 6), salivary androstenedione 
levels have been reported to be 59.78 ± 18.63 pg/ml 
(am) and 66.64 ± 47.02 pg/ml (pm). By ages 15-16 (n 
= 8), the values have increased to 233.16 ± 102.97 pg/
ml (am), and 171.94 ± 43.59 pg/ml (pm).15 In contrast, 
in prepubescent girls with hyperandrogenism, salivary 
androstenedione levels are as high as 400 pg/ml in 
the morning, and similar to levels for adult women in 
the evening.23 Based on these values, the salivary 
androstenedione levels (see Table I) in the current study 
seem to fall within the expected range for young girls. 
However, the lack of normative data, relating to salivary 
androstenedione levels in healthy and unhealthy 
young girls, makes this statement speculative.
In our cohort, overweight or obese girls did not 
demonstrate hyperandrogenaemia (elevated salivary 
androstenedione levels), compared with normal-
weight girls. However, there were significant positive 
correlations between salivary androstenedione at 30 
minutes post-waking and indices of adiposity (body 
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Figure 1: Daily salivary androstenedione values (mean ± standard 
deviation) according to physical activity level status 





























Figure 2: Salivary androstenedione levels in different female 
populations 15,23 compared with values in the normal-weight and 
overweight or obese girls in the current study
Table IV: Differences in daily salivary androstenedione levels (upon 
waking, 30 minutes post-waking and in the evening) by meeting 
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with the literature, that has demonstrated that 
excessive adiposity promotes hyperandrogenaemia in 
adolescent girls and adult women,4,5 and contributes 
to the limited information available on androgens in 
overweight or obese children, specifically prepubertal 
and adolescent girls. 
Currently, the literature is conflicting regarding androgen 
levels in obesity in young girls. Hyperandrogenaemia 
has been suggested to only occur after menarche,24 
while lower testosterone levels have been reported in 
prepubertal obese girls, compared with normal-weight 
girls.25 In contrast, research has demonstrated similar 
testosterone concentrations in obese and normal-
weight prepubertal girls,26,27 whereas studies on obese 
female adolescents showed higher testosterone levels, 
compared with lean adolescents.14,28 In addition, 
testosterone and dehydroepiandrosterone (DHEA) 
sulfate levels have been shown to increase in obese 
prepubertal children,8,26,27 obese pubertal girls, and 
obese female adolescents,14,28 compared with normal-
weight children of the same age, gender and pubertal 
stage. 
It has been suggested that hormonal, adipokine, and 
pro-inflammatory mechanisms, are responsible for the 
elevation of androgens in obesity. Corticotrophin-
releasing hormone (CRH), which is activated with 
increased adiposity, has been found to increase 
adrenal androgen secretion directly.29 The adipose 
cell-derived hormone, leptin, has also been shown to 
promote the formation of adrenal androgens,30 and 
to regulate the onset of puberty,31,32 while a low level 
of adipose cell-derived adiponectin is associated 
with hyperandrogenism in adolescent girls.33 Recently, 
polymorphisms in the pro-inflammatory interleukin 
(IL)-6 receptor complex have been associated with 
hyperandrogenism.34 Finally, a correlation between 
insulin levels and androgen secretion has been 
reported,35 specifically between insulin and testosterone 
in obese children,36 and insulin and DHEA sulfate during 
puberty.37,38 Whether any of these mechanisms are 
associated with regulating salivary androstenedione 
levels in overweight or obesity is presently unknown, 
and should be the focus of future research.
The finding that time spent on vigorous physical 
activity is associated with reduced adiposity, and the 
fact that girls classified as meeting physical activity 
recommendations had reduced evening salivary 
androstenedione levels, suggest an important role 
of physical activity in the regulation of androgenic 
risk in young girls. The literature indicates that 
androstenedione follows a diurnal rhythm, with higher 
levels in the morning, and lower levels in the afternoon 
or evening, similar to that of cortisol.39 Although the 
ANOVA only found differences in the evening salivary 
androstenedione, and not at waking, or 30 minutes 
post-waking, the results suggest that the diurnal 
rhythm of those girls not meeting physical activity 
recommendations was altered. A similar alteration 
of diurnal rhythm has been demonstrated for salivary 
cortisol, which was associated with a less favourable 
metabolic profile.40
Previous research has demonstrated that weight 
loss, in response to a behavioural, exercise, and 
nutrition intervention, decreased serum testosterone in 
prepubertal children and pubertal girls.4 Reductions in 
testosterone, in response to weight loss interventions, 
have also been demonstrated in obese women and 
female adolescents, after menarche.4 These findings 
point to a reversible increase of androgens, due to 
obesity. Although the present study examined the 
relationship between physical activity levels and 
salivary androstenedione, and not the impact of 
a physical activity intervention, the result suggests 
that performing 60 minutes of moderate-to-vigorous 
physical activity per day may be responsible for 
maintaining appropriate daily androgenic activity in 
young girls. 
Limitations
This study is not without limitations. While the physical 
activity levels were measured through the use of an 
accelerometer to obtain a more accurate measure of 
physical activity compared to self-report, the epoch 
length was set at one-minute intervals. Children’s 
physical activity patterns are intermittent by nature, 
and vary in intensity.41,42 By setting the epoch length 
at one minute, it is likely that short bursts of either 
moderate, or vigorous, physical activity, were not 
detected. Further, the accelerometer does not 
measure specific activities, such as swimming and 
bike riding, which are activities that young children 
often partake in. These limitations could result in 
undercalculating the amount of time spent on 
moderate and vigorous physical activity. However, 
McClain et al43 reported that when comparing direct 
observation with different epoch lengths in 10-year-
old boys and girls, similar amounts of time spent on 
moderate-to-vigorous physical activity were measured, 
regardless of the epoch length. Further, when the 
relationship between short (≥ 4 seconds) and long 
(≥ 5 minutes) physical activity bouts and health 
outcomes was examined in eight-to ten-year-old boys, 
the long bouts resulted in similar strength correlations as 
the short ones.44 
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Conclusion
While the present study demonstrated a relationship 
between adiposity and salivary androstenedione 
in young girls, the results suggest an additional 
physical activity-related mechanism that regulates 
their androgen levels. This mechanism may operate 
independently of reduced adiposity in optimising 
androgen levels in young girls. Further research is 
required to determine whether an appropriate 
androgen level, or diurnal rhythm, is associated with 
improved CRH, and/or insulin, and/or adipokine/
inflammatory profiles in young girls, in response to 
increased moderate-to-vigorous physical activity.
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